SustaTrex 350mg/ml 10ml Vial by Concentrex Labs

Usage

1. Calculate your target weekly testosterone dose in milligrams and divide by 350 to determine total millilitres per week; split the weekly volume across two injections (e.g. Monday / Thursday) to align with HGH's daily administration schedule.
2. Swab the SustaTrex vial septum with 70% isopropyl alcohol and allow it to dry before every draw; this sterility step is especially critical when the same vial is accessed repeatedly over a 16–24 week HGH cycle.
3. Draw the required volume using a 21–23 gauge needle, confirm the measurement against the syringe barrel (each 0.1 ml = 35 mg at this concentration), then swap to a 23–25 gauge injection needle to administer intramuscularly into the glute, vastus lateralis, or deltoid.
4. Rotate injection sites systematically — alternating between left and right within each anatomical region — to prevent local tissue accumulation across the extended injection frequency that HGH protocols demand.
5. Administer HGH separately from SustaTrex on the days they coincide; HGH is typically injected subcutaneously in the morning or post-training, while SustaTrex is injected intramuscularly — different routes, sites, and timing requirements apply.
6. Schedule bloodwork at baseline, cycle week six, and cycle week twelve minimum, measuring total testosterone, free testosterone, estradiol, IGF-1, and haematocrit to confirm both the androgenic and growth-hormone axes are operating within targeted ranges.

Warnings

Frequently asked questions

Can SustaTrex 350mg/ml be safely combined with recombinant human growth hormone in the same cycle?

Yes — SustaTrex and HGH target different anabolic pathways and do not compete pharmacologically. Testosterone acts through androgen receptors in muscle tissue, while HGH drives IGF-1 production via GH receptors in the liver and peripherally in muscle. Running both simultaneously produces complementary stimuli: sustained androgenic receptor occupancy from SustaTrex amplifies the anabolic response to HGH-driven IGF-1, making the combination more productive than either compound run alone at equivalent doses.

What synergies does stacking SustaTrex with HGH offer for lean muscle and body composition?

The primary synergy is pathway complementarity. SustaTrex maintains continuous androgenic signalling through its four-ester release profile, which research (Hameed et al., 2004) shows potentiates local IGF-1 splice variant expression in skeletal muscle. HGH simultaneously elevates systemic and local IGF-1, accelerates lipolysis through hormone-sensitive lipase activation, and improves collagen synthesis in connective tissue. The result is simultaneous lean-mass accretion and body-fat reduction, which is difficult to achieve with either compound independently at body-composition-appropriate doses.

How do you structure injection timing when running SustaTrex alongside a daily HGH protocol?

HGH is typically injected daily or five days on / two days off, most often in the morning on an empty stomach or post-training to leverage natural GH pulse timing. SustaTrex at 350 mg/ml is administered twice weekly — for example Monday and Thursday — regardless of daily HGH scheduling. The two compounds do not share injection sites or timing requirements, so no adjustment to either schedule is necessary. The four-ester blend's pharmacokinetic spread maintains androgenic coverage across the full seven-day HGH administration week.

How do I draw an accurate dose from a 350mg/ml multi-dose vial using an insulin syringe?

At 350 mg/ml, each 0.1 ml graduation on a standard 1 ml syringe delivers 35 mg of testosterone ester blend. A 1 ml draw equals 350 mg; a 1.5 ml draw equals 525 mg. Use a fresh 21–23 gauge drawing needle to pull from the vial, then swap to a 23–25 gauge injection needle. Confirm the volume against the syringe barrel before injection to avoid measurement error, particularly important in HGH co-administration protocols where weekly testosterone targets are precisely planned.

What are the correct storage conditions for a SustaTrex 10 ml vial after the first draw?

After the first puncture, store the SustaTrex vial at room temperature (15–25 °C), away from direct light and heat. Refrigeration is not required and may cause the oil carrier to thicken, making accurate drawing more difficult. Once opened, the vial should be used within 28 days; do not use if the solution becomes cloudy or shows visible particulate matter. Swab the rubber septum with 70% isopropyl alcohol before every draw to maintain sterility across the multiple uses expected in a 16–24 week HGH-inclusive cycle. (2) angle_used

Manufacturer

Concentrex Labs sources the API for SustaTrex — all four ester fractions of testosterone — through a documented raw-material procurement pathway that begins with origin verification against pharmacopoeial reference standards before a single kilogram enters the compounding facility. Each incoming ester fraction is cross-checked by in-house analytical chemists: identity, purity, and concentration are confirmed via HPLC against a certified reference standard, and any lot failing to meet acceptance criteria is rejected at intake rather than quarantined post-fill. This upstream verification philosophy reflects the brand's understanding that API origin and purity are the rate-limiting variables in finished-product quality — a point that becomes commercially relevant for athletes planning HGH-inclusive cycles lasting 20 or more weeks, where batch-to-batch consistency across multiple SustaTrex orders determines whether the androgenic baseline of the stack remains stable from the first vial to the last. Finished-product HPLC confirms declared ester proportions and total 350 mg/ml concentration within the validated acceptance range; LAL endotoxin testing provides the parenteral-safety gate. Documentation covering both analytical stages accompanies each batch record, making the data available for distribution-chain verification.